FACTORS INFLUENCING NORTRIPTYLINE STEADY-STATE KINETICS - PLASMA AND SALIVA LEVELS

被引：46
|
作者：
KRAGHSORENSEN, P [1 ]
LARSEN, NE [1 ]
机构：
[1] COPENHAGEN CTY HOSP,DEPT CLIN CHEM,GLOSTRUP,DENMARK
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1980年 / 28卷 / 06期
关键词：
D O I：
10.1038/clpt.1980.237
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：796 / 803
页数：8
相关论文
共 50 条
  • [31] STEADY-STATE PLASMA IMIPRAMINE LEVELS IN PREPUBERTAL DEPRESSED CHILDREN
    WELLER, EB
    WELLER, RA
    PRESKORN, SH
    GLOTZBACH, R
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1982, 139 (04): : 506 - 508
  • [32] PREDICTION OF STEADY-STATE PLASMA-LEVELS OF AMITRIPTYLINE AND NORTRIPTYLINE FROM A SINGLE DOSE 24 HR LEVEL IN DEPRESSED-PATIENTS
    BRUNSWICK, DJ
    AMSTERDAM, J
    SCHLESS, A
    ROTHBART, M
    SANDLER, K
    MENDELS, J
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1980, 41 (10) : 337 - 340
  • [33] PREDICTION OF STEADY-STATE PLASMA AND SALIVA LEVELS OF DESIPRAMINE - A SINGLE-DOSE, SINGLE-TIME-POINT PROCEDURE
    COOPER, TB
    SIMPSON, GM
    BARK, N
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 238 - 238
  • [34] STEADY-STATE PLASMA-LEVELS OF E-10-OH-NORTRIPTYLINE AND Z-10-OH-NORTRIPTYLINE IN NORTRIPTYLINE-TREATED PATIENTS - SIGNIFICANCE OF CONCURRENT MEDICATION AND THE SPARTEINE OXIDATION PHENOTYPE
    GRAM, LF
    BROSEN, K
    KRAGHSORENSEN, P
    CHRISTENSEN, P
    [J]. THERAPEUTIC DRUG MONITORING, 1989, 11 (05) : 508 - 514
  • [35] STEADY-STATE LEVELS OF LORAZEPAM
    VALLI, M
    JADOT, G
    HARITON, C
    CARABOEUF, A
    CALVET, P
    SCOTTO, JC
    BOUYARD, P
    [J]. THERAPIE, 1983, 38 (06): : 706 - 707
  • [36] STEADY-STATE PLASMA IN A PLANE
    HURLEY, JP
    [J]. PHYSICS OF FLUIDS, 1965, 8 (06) : 1139 - &
  • [37] SOME FACTORS THAT INFLUENCE THE STEADY-STATE IN STEADY-STATE FREE PRECESSION
    PATZ, S
    [J]. MAGNETIC RESONANCE IMAGING, 1988, 6 (04) : 405 - 413
  • [38] COMPARISON OF PLASMA AND SALIVA CONCENTRATIONS OF THE ACTIVE MONOHYDROXY METABOLITE OF OXCARBAZEPINE IN PATIENTS AT STEADY-STATE
    CARDOT, JM
    DEGEN, P
    FLESCH, G
    MENGE, P
    DIETERLE, W
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1995, 16 (07) : 603 - 614
  • [39] EFFECT OF PLASMA-EXCHANGE ON THE STEADY-STATE KINETICS OF DIGOXIN AND DIGITOXIN
    KELLER, F
    KREUTZ, G
    VOHRINGER, HF
    OFFERMANN, G
    DISTLER, A
    [J]. CLINICAL PHARMACOKINETICS, 1985, 10 (06) : 514 - 523
  • [40] 2 PROSPECTIVE DOSING METHODS FOR PREDICTING STEADY-STATE NORTRIPTYLINE CONCENTRATIONS
    PERRY, PJ
    BROWNE, JL
    ALEXANDER, B
    TSUANG, MT
    SHERMAN, AD
    DUNNER, FJ
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06): : 514 - 514
12345